Skip to main content

For questions about financial assistance, call 1-844-DUPIXENT, option 1 or
click to learn more  

DUPIXENT is a prescription medicine used to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies.

RESULTS IN ADULTS

Rachel,
Actual DUPIXENT patient
since 2017.
Individual results may vary.

View before and after photos with DUPIXENT IN ADULTS

Click and drag
to see results
dragging icon

Before
Treatment

After Treatment
with dupixent
at 16 weeks

Click and drag
to see results
dragging icon

Before
Treatment

After Treatment
with dupixent
at 16 weeks

Actual real-world DUPIXENT patients shown; not clinical trial patients. Additional factors (including possible use of other treatments) may have impacted results. Individual results may vary.

Stay ahead of eczema that keeps coming back

Results from 2 clinical trials of adults with moderate-to-severe eczema at 16 weeks:

4X
saw clear or
almost clear skin

37% on DUPIXENT vs
9% not on DUPIXENT

>3X
had significant
itch reduction

38% on DUPIXENT vs
11% not on DUPIXENT

Almost half of adults saw

≥75%
clearer
skin

48% on DUPIXENT vs 13% not on DUPIXENT

Many saw

≥90%
clearer
skin

33% on DUPIXENT vs 7% not on DUPIXENT

Have you spoken to a dermatologist or allergist about DUPIXENT?

Great! Sign up for DUPIXENT MyWay®, our patient support program, to access program services and get one-on-one support every step of the way, including help with filling your first prescription.

If you're still struggling with moderate-to-severe eczema, maybe it's time to change the conversation.

Answer a few short questions about your eczema symptoms and treatment goals. We’ll turn it into a personalized discussion guide you can use at your next visit.

Specialists like dermatologists or allergists often have more experience treating moderate-to-severe eczema and can help create a personalized care plan for you.

Long-term results with DUPIXENT

Results from a clinical trial that studied DUPIXENT for 12 months:

Long-lasting clearer skin

At 4 months: 39% on DUPIXENT +
TCS vs 12% on TCS only

At both 4 months and 12 months:
22% on DUPIXENT + TCS vs 7%
on TCS only

Itch relief that lasts

At 12 months: 51% on DUPIXENT + TCS
vs 13% on TCS only

Fast itch relief after the first dose

At 2 weeks: 18% on DUPIXENT +
TCS vs 8% on TCS only

TCS, topical corticosteroids.

DEMONSTRATED
long-term safety profile

Long-term safety results for adults continuing on DUPIXENT in an extension study through 5 years were consistent with those seen in the original clinical trials.

Most common side effects include:

  • Injection site reactions
  • Eye problems, including eye and eyelid inflammation, redness, swelling, itching, eye infection, dry eye, and blurred vision
  • Cold sores in your mouth or on your lips
  • High count of a certain white blood cell (eosinophilia)

View the possible side effects of DUPIXENT


What you should know about the adult patients in these studies:

52%
Had moderate
atopic dermatitis
48%
Had severe
atopic dermatitis
~38 years
Average age
~28 years
Average duration

of the disease
~55%
Average body
surface
area
involvement

Stay connected

Feel like you're struggling with your symptoms?
Sign up for information that can help.